We’ve all been there.

It's 10 pm on a Sunday. The kids are finally in bed. You're about to wind down, maybe scroll mindlessly through social media for a few minutes before calling it a night.

Then it hits you. Tomorrow's investor meeting.

A small wave of panic settles in your gut.

Do I know what I want to say? Do I just run through my pitch deck like usual? Who are these guys, anyway? I don't think I've actually heard much about their fund. Oh well - we only have 30 minutes. I'll run through my deck, take their questions, and if they're interested, we'll schedule a follow-up.

Sound familiar?

Now here's the other version I see just as often.

This one comes from the same realization, but instead of shrugging it off, this founder sits up in a quiet panic while their spouse sleeps a deep sleep next to them.

They open their laptop and start guerilla googling. The investor's name. The firm's portfolio. The partner's LinkedIn. Their podcast appearances from 2019. A press release about a deal they did three years ago.

By 3am they have 54 browser tabs open and no clear idea what to actually do with any of it.

These are two founders with two separate approaches, but the same result: walking into a meeting without a real plan.

What makes this even more painful is that investor meetings are not unlimited. You don't get hundreds of at-bats.

Every meeting that doesn't convert is one fewer shot at your round coming together on time.

The honest truth is that most founders don't know how much time to spend prepping, what to focus on, or what “ready enough” actually looks like. So they default to one of those two extremes - wing it or over-research, because nobody ever gave them a system.

That's what I want to fix today.

I’d like to share with you a framework to prep for any investor meeting in 30 minutes.

This is a framework I've been using myself and with founders I work with for years, and it's consistently shown results. The thing is, I've always kept it informal and in my head.

So today I'm finally putting it on paper and sharing it with you.

Let's get into it.

Over the years, both on the investor side and working with early-stage founders, I've noticed clear patterns in who shows up with the most clarity and who builds the strongest connections with investors, even when time is limited.

I gave a lot of thought to what those founders were doing differently, and how to break it down into something repeatable.

The READY system is the result. It’s five steps that should require no more than 30 minutes, and it can be applied to any investor type - whether it's an angel, family office, VC, you name it.

Let's break it down.

This is a targeted scan, not a deep dive. You're looking for five things:

1) Who is the specific person you're meeting? (Not just the firm, but the exact invididual you’re speaking to). Do you have any common points of interest - where they studied, their PhD thesis subject, what city they’re in, etc?

2) What is their fund's stated thesis? (Sector, focus area, stage)

3) When did they raise their current fund? (A fund that closed several years ago may be nearly fully deployed - this matters more than most founders realize.)

4) What are their 2-3 most recent investments? (This tells you what they're actually doing, not just what their website says.)

5) Have they invested in anything adjacent to your space? (Competitors, complementary companies, or platform plays that overlap with yours.)

Where to look: the firm's website, Crunchbase, LinkedIn, and a quick Google News search.

Now, not all of this information may be publicly available, and that's completely fine. What you find gives you a starting point, and any gaps become great questions to ask during the meeting (more on that below).

The key is showing enough context to have an informed conversation. Investors can always tell the difference between a founder who asks a thoughtful question because the answer wasn't available, and one who didn't take 5 minutes to look it up in the first place.

This is the step most founders skip, and it's the one that saves you the most time over the course of a fundraise.

Before you spend energy prepping your pitch, run a quick pass/fail on three dimensions:

Stage fit: Do they invest at your stage? Do they advertise themselves as a pre-seed fund, as being the “first check”, or are they a growth fund that looks to be the last money in before a liquidity event like an IPO?

Sector fit: Is your space within their thesis? If you're building a diagnostics company and they only do therapeutics, the meeting might still be worth taking for the relationship but adjust your expectations accordingly.

Check size match: Does their typical investment size align with your round? If you're raising $800K and they only write $2-5M checks, it’s likely the meeting will focus more on relationship building for the future.

If the answer is “no” on two of three - seriously reconsider whether this meeting deserves your prime energy, or whether it's a lower-priority networking conversation. Not every meeting is a pitch, and that’s ok. But it’s important to know the difference, because it changes how you show up.

This is also a good time to check for portfolio conflicts. If they've already invested in a company that competes directly with yours, that's critical context to have before the meeting, not during it.

This is the highest-leverage step in the entire system, and if you’re a Bio Founder GPS subscriber, it should feel familiar.

Here's the core idea: not every investor needs to hear the same version of your story. An angel investor, a family office, a micro-VC, and an established biotech VC are all evaluating you through fundamentally different lenses. If you pitch a family office the same way you pitch a deep-domain VC, you're leaving value on the table.

Here's a quick breakdown of what each archetype is listening for:

Angel investors (especially non-industry angels) want to understand the human impact of what you're building. They want to know why this problem matters, why you're the person to solve it, and how they get their money back. Lead with the story. Keep the science accessible. Give them concrete exit examples they can wrap their heads around.

Family offices that invest directly in life sciences startups (as opposed to just being LPs in venture funds) often do so because of strong mission alignment - a personal connection to a disease area, a family member affected, or a deep belief in the space. If that alignment exists with your company, bring it to the forefront. Beyond mission, they tend to care about capital preservation and downside protection. Show them you're thinking about risk as rigorously as you think about the science.

Micro-VCs are looking for capital efficiency and clear milestones. They write smaller checks into earlier stages, which means they need to believe your next 12-18 months of progress will unlock the next round. Show them you know exactly what the money buys and what it proves.

Established biotech VCs have deep domain expertise, often with multiple PhDs and MDs on staff. They've seen hundreds of pitches in your space. Don't over-explain the basics. Instead, go deep on what's truly differentiated about your science, the rigor of your data, and your competitive positioning. They'll be checking whether your understanding of the landscape is as sharp as theirs.

Corporate venture (CVC) investors are evaluating strategic fit with their parent company. They want to know if working with you could lead to a partnership, a licensing deal, or eventually an acquisition. Research the parent company's pipeline and therapeutic focus before the meeting - it signals that you understand their world, not just your own.

Your 10 minutes here: identify which archetype you're meeting, pull up 2-3 talking points to emphasize for that archetype, and, just as importantly: note 1-2 things to de-emphasize or trim from your standard pitch. You're not rewriting your deck. You're adjusting the emphasis.

Most founders think of Q&A as the part of the meeting where they’re in the hot seat. But the questions you ask tell an investor just as much about you as the answers you give.

Now, there are the table stakes questions: how actively they're deploying capital, typical check size, whether they follow on, their timeline from first meeting to decision - those are important. Definitely ask them. But know that they’re not going to be the questions that the investor will remember.

The questions that do set you apart are the ones that build genuine connection and show you've thought about this investor as a person, not just a check.

Here are three themes to consider:

The homework question: something that connects your research to their portfolio. “I noticed you invested in [portfolio company] - we're approaching [specific problem] from a different angle. I'm curious how you think about [specific area] within your thesis?” This shows you've done the work, but it also opens a conversation directly relevant to your company

The perspective question: something that invites their view on a trend or challenge that directly affects your company. “We're seeing [specific market shift or technical trend] reshape how [your sector] is being built. Is that something you're seeing across your portfolio?” or “One thing we're wrestling with is [specific strategic decision]. How have you seen other companies in your portfolio navigate that?” These questions do double duty - you get genuinely useful input on a real decision you're facing, and the investor gets to see how you think.

The fit question: something that honestly tests whether this is the right partnership. “Based on what you've heard today, does this feel like something that fits within your current thesis?” or “What would you need to see from us to feel confident in taking a next step?” This takes guts to ask, but it signals maturity and saves both of you time.

Now take everything you've gathered and compile it into a single pre-meeting cheat sheet. One page, nothing fancy - a Google Doc, a note on your phone, whatever works.

Here's what goes on it:

The investor's name, firm, and role. Their thesis in one sentence. 1-2 portfolio companies relevant to your space. The investor archetype and your adjusted talking points. Your 3 questions. Your specific ask (round size, use of funds, what you're looking for in a lead).

This is your pre-meeting ritual. You glance at it in the Uber on the way there. You review it for 5 minutes before the Zoom. It keeps you grounded, focused, and - most importantly, it keeps you from defaulting back to your generic pitch when the nerves kick in.

While the READY system is a great quick prep for most investor meetings, some will be higher priority - the investors who could write your lead check or whose brand would transform your credibility.

For those, the same components apply: just go deeper and give yourself double the time for each section. The 60 minutes actually does you a favor: it's enough time to prepare thoroughly, but it's also finite. It gives you a clear stopping point so you don't spiral into endless prep. It follows the same logic and the same structure, just with more depth.

To make the READY system even easier to use, I put together an AI mega prompt that does the heavy lifting for you.

Paste it into ChatGPT, Claude, or Gemini, plug in the investor's name and your company details, and it generates a complete pre-meeting intelligence brief - covering investor background, thesis fit, anticipated questions they're likely to ask based on their archetype, and smart questions you can bring to the conversation.

Think of it as your READY system on autopilot.

👉 [Get the Meeting Brief Mega Prompt here]

As always: AI tools are powerful but not perfect. They can occasionally get names, credentials, or investment history wrong. Always verify the key details before your meeting.

Hopefully by now you see that preparing for investor meetings doesn't have to be a 3am spiral or a “hope for the best” situation. A focused 30 minutes with a clear system can completely change how you show up and how investors perceive you.

The READY framework isn't complicated. But that’s the point. I’ve seen these steps work time and time again with founders, and I hope they work for you too.

Try it alongside the mega-prompt before your next meeting and let me know how it goes. I'd love to hear your feedback - reply to this email and tell me what worked, what didn't, and what you'd add. I’d love to continue building these tools together.

If you have investor meetings coming up and want to make sure your deck is doing your science justice, I offer a Pitch Deck Audit where we go through your materials together and make sure your story, positioning, and ask are dialed in for the investors you're targeting. I also help you put together a tailored list of angel groups, family offices, micro-VCs, and traditional venture funds that could be a good fit for your specific company and stage.

I've done five of these since launching last month and honestly have been humbled by the feedback I've gotten from founders. If this is something that could be helpful for you, let's chat! Feel free to reply to this email if you have any questions.

[You can learn more here]

See you next Sunday!

- Vadim

PS: I previously wrote a detailed breakdown of the 5 biotech investor archetypes and how to tailor your pitch for each one (it was actually the very first Bio Founder GPS post!). If you want to go deeper on investor archetypes, you can find it here.